ONKURE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ONKURE THERAPEUTICS, INC. (OKUR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 39.78 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-04
- ONKURE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 12.73K shares, a 75.36% decline year-over-year.
- ONKURE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 27.06K shares, a 56.73% decline year-over-year.
- ONKURE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 0.00 shares.
- ONKURE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 291.38K shares.
- ONKURE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 405.57K shares, a 54706.35% increase from fiscal 2024.
- ONKURE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 740.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 12.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 39.78K shares 10-Q · filed 2026-08-04 | 39.78K shares derived: sum of 3 quarters · filed 2026-08-04 | 331.16K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 27.06K shares 10-Q · filed 2026-05-05 | 27.06K shares derived: sum of 2 quarters · filed 2026-05-05 | 318.44K shares derived: sum of 3 quarters · filed 2026-05-05 | 370.09K shares derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 291.38K shares derived: sum of 2 quarters · filed 2026-03-12 | 343.03K shares derived: sum of 3 quarters · filed 2026-03-12 | 405.57K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 291.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 343.03K shares derived: sum of 2 quarters · filed 2025-11-06 | 405.57K shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 51.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 114.19K shares 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | 62.54K shares 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | 740.00 shares 10-K · filed 2025-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |